SCHEMBL22097

SCHEMBL22097

FC1(F)CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7026104 1.00
SCHEMBL287369 1.00
SCHEMBL12212857 1.00
Hydrochloric Acid SCHEMBL15200590 0.96
Ammonia Solution, Strong SCHEMBL18669656 0.96
SCHEMBL562817 0.95
Hydrochloric Acid SCHEMBL27776273 0.92
Ammonia Solution, Strong SCHEMBL21357306 0.91
Hydrochloric Acid SCHEMBL28816648 0.91
Methyl Alcohol SCHEMBL29259241 0.89 ALDH1A1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1752 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3824878-B1 ABUSE RESISTANT CAPSULE SCHERER TECHNOLOGIES LLC R P (US) 2025-11-12 EP claimed
US-12404283-B2 c-MYC mRNA translation modulators and uses thereof in the treatment of cancer ANIMA BIOTECH INC. (US) 2025-09-02 US claimed
EP-4547672-A1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER Anima Biotech Inc. (US) 2025-05-07 EP claimed
US-20250129100-A1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER ANIMA BIOTECH INC. (US) 2025-04-24 US claimed
CN-119345757-A Organic silicon defoaming composition and preparation method thereof 范丽芳 2025-01-24 CN claimed
US-20250002868-A1 ADENO-ASSOCIATED VIRUS SEPARATION ON A CATION EXCHANGER TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2025-01-02 US claimed
CN-119233976-A Modulators of c-MYC mRNA translation and their use in the treatment of cancer 艾尼莫生物科技公司 2024-12-31 CN claimed
US-12133922-B2 Abuse resistant capsule R.P. SCHERER TECHNOLOGIES, LLC (US) 2024-11-05 US claimed
EP-3471697-B1 CHEMICAL COMPOSITION UNIV LIVERPOOL (GB) 2024-09-04 EP claimed
CN-118510506-A Aqueous composition comprising avermectin 荷维制药服务有限公司 2024-08-16 CN claimed
US-6475595-B1 ELECTROOPTICS MERCK GMBH (DE) 2002-11-05 US claimed
US-20020120168-A1 Difluoromethyl ether derivative and process for producing the same JNC PETROCHEMICAL CORPORATION (JP) 2002-08-29 US claimed
EP-1182186-A2 Difluoromethyl ether derivative and process for producing the same CHISSO CORPORATION (JP) 2002-02-27 EP claimed
EP-0861235-B1 SUBSTITUTED BENZYLAMINOPIPERIDINE COMPOUNDS PFIZER (US) 2001-11-07 EP claimed
EP-0861235-A1 SUBSTITUTED BENZYLAMINOPIPERIDINE COMPOUNDS PFIZER INC. (US) 1998-09-02 EP claimed
WO-1997008144-A1 SUBSTITUTED BENZYLAMINOPIPERIDINE COMPOUNDS PFIZER PHARMACEUTICALS INC. (JP) 1997-03-06 WO claimed
EP-0138669-B1 PROCESS FOR THE PREPARATION OF SILANES FROM METHYLDICHLOROSILANE AND CHLOROSILANES RHONE-POULENC CHIMIE (FR) 1988-08-10 EP claimed
EP-0138670-B1 PROCESS FOR THE PREPARATION OF SILANES WITH A SI-H BOND BY REDISTRIBUTION RHONE-POULENC CHIMIE (FR) 1988-05-25 EP claimed
US-4746752-A QUATERNARY OR TERTIARY AMINE CATALYST RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1988-05-24 US claimed
US-4605543-A DISTRIBUTION AND DISPROPORTIONATION CATALYSIS RHONE-POULENC SPECIALITIES CHIMIQUES (FR) 1986-08-12 US claimed